{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T12:58:36Z","timestamp":1781787516762,"version":"3.54.5"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005421","name":"Guilan University of Medical Sciences","doi-asserted-by":"publisher","award":["1401072506"],"award-info":[{"award-number":["1401072506"]}],"id":[{"id":"10.13039\/501100005421","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12092-3","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T12:38:00Z","timestamp":1781786280000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative analysis of antibacterial and antibiofilm activity of nickel oxide nanoparticles among uropathogenic Escherichia coli O-serotypes isolated from patients with urinary tract infections based on molecular typing"],"prefix":"10.1007","volume":"53","author":[{"given":"Parisa","family":"Najafi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0760-1338","authenticated-orcid":false,"given":"Raheleh","family":"Sheikhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi Sedigh","family":"Ebrahim-Saraie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Mirsaeidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elahe","family":"Keshavarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"12092_CR1","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3390\/pathogens12040623","volume":"12","author":"G Mancuso","year":"2023","unstructured":"Mancuso G, Midiri A, Gerace E, Marra M, Zummo S, Biondo C (2023) Urinary tract infections: The current scenario and future prospects. Pathogens 12:623. https:\/\/doi.org\/10.3390\/pathogens12040623","journal-title":"Pathogens"},{"key":"12092_CR2","doi-asserted-by":"publisher","unstructured":"Zhou Y, Zhou Z, Zheng L, Gong Z, Li Y, Jin Y et al. (2023) Urinary tract infections caused by uropathogenic Escherichia coli: Mechanisms of infection and treatment options. Int J Mol Sci 24:10537. https:\/\/doi.org\/10.3390\/ijms241310537","DOI":"10.3390\/ijms241310537"},{"key":"12092_CR3","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/femsre\/fuz028","volume":"44","author":"B Liu","year":"2020","unstructured":"Liu B, Furevi A, Perepelov AV, Guo X, Cao H, Wang Q et al (2020) Structure and genetics of Escherichia coli O antigens. FEMS Microbiol Rev 44:655\u2013683. https:\/\/doi.org\/10.1093\/femsre\/fuz028","journal-title":"FEMS Microbiol Rev"},{"key":"12092_CR4","doi-asserted-by":"publisher","unstructured":"Sharma S, Kaur N, Malhotra S, Madan P, Ahmad W, Hans C (2016) Serotyping and antimicrobial susceptibility pattern of Escherichia coli isolates from urinary tract infections in pediatric population in a tertiary care hospital. J Pathog 2016: 2548517. https:\/\/doi.org\/10.1155\/2016\/2548517","DOI":"10.1155\/2016\/2548517"},{"key":"12092_CR5","doi-asserted-by":"publisher","first-page":"644","DOI":"10.3389\/fmicb.2016.00644","volume":"7","author":"PM Fratamico","year":"2016","unstructured":"Fratamico PM, DebRoy C, Liu Y, Needleman DS, Baranzoni GM, Feng P (2016) Advances in molecular serotyping and subtyping of Escherichia coli. Front Microbiol 7:644. https:\/\/doi.org\/10.3389\/fmicb.2016.00644","journal-title":"Front Microbiol"},{"key":"12092_CR6","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.19082\/2291","volume":"8","author":"MA Ardakani","year":"2016","unstructured":"Ardakani MA, Ranjbar R (2016) Molecular typing of uropathogenic E. coli strains by the ERIC-PCR method. Electron Physician 8:2291\u20132296. https:\/\/doi.org\/10.19082\/2291","journal-title":"Electron Physician"},{"key":"12092_CR7","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.biopha.2017.08.006","volume":"94","author":"S Khoshnood","year":"2017","unstructured":"Khoshnood S, Heidary M, Mirnejad R, Bahramian A, Sedighi M, Mirzaei H (2017) Drug-resistant gram-negative uropathogens: A review. Biomed Pharmacother 94:982\u2013994. https:\/\/doi.org\/10.1016\/j.biopha.2017.08.006","journal-title":"Biomed Pharmacother"},{"key":"12092_CR8","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.3390\/microorganisms10061103","volume":"10","author":"V Ball\u00e9n","year":"2022","unstructured":"Ball\u00e9n V, Cepas V, Ratia C, Gabasa Y, Soto SM (2022) Clinical Escherichia coli: From biofilm formation to new antibiofilm strategies. Microorganisms 10:1103. https:\/\/doi.org\/10.3390\/microorganisms10061103","journal-title":"Microorganisms"},{"key":"12092_CR9","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.3390\/antibiotics11121826","volume":"11","author":"H Alaoui Mdarhri","year":"2022","unstructured":"Alaoui Mdarhri H, Benmessaoud R, Yacoubi H, Seffar L, Guennouni Assimi H, Hamam M (2022) Alternatives therapeutic approaches to conventional antibiotics: Advantages, limitations and potential application in medicine. Antibiot (Basel) 11:1826. https:\/\/doi.org\/10.3390\/antibiotics11121826","journal-title":"Antibiot (Basel)"},{"key":"12092_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.15171\/ijbsm.2019.14","volume":"4","author":"G Ilbeigi","year":"2019","unstructured":"Ilbeigi G, Kariminik A, Moshafi MH (2019) The antibacterial activities of NiO nanoparticles against some gram-positive and gram-negative bacterial strains. Int J Basic Sci Med 4:69\u201374. https:\/\/doi.org\/10.15171\/ijbsm.2019.14","journal-title":"Int J Basic Sci Med"},{"key":"12092_CR11","doi-asserted-by":"publisher","first-page":"6915","DOI":"10.53730\/ijhs.v6nS7.13692","volume":"6","author":"SS Hasson","year":"2022","unstructured":"Hasson SS, Alsammarraie AM (2022) Synthesis of nickel oxide nanoparticles by sol-gel method. Int J Health Sci 6:6915\u20136924. https:\/\/doi.org\/10.53730\/ijhs.v6nS7.13692","journal-title":"Int J Health Sci"},{"key":"12092_CR12","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s12859-015-0703-0","volume":"16","author":"J Heras","year":"2015","unstructured":"Heras J, Dom\u00ednguez C, Mata E, Pascual V, Lozano C, Torres C et al (2015) GelJ\u2013a tool for analyzing DNA fingerprint gel images. BMC Bioinformatics 16:270. https:\/\/doi.org\/10.1186\/s12859-015-0703-0","journal-title":"BMC Bioinformatics"},{"key":"12092_CR13","unstructured":"CLSI. Clinical and Laboratory Standards Institute (2021) Performance standards for antimicrobial susceptibility testing, thirty firth informational supplement. CLSI Document M100-S31, Wayne, Pennsylvania, USA"},{"key":"12092_CR14","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/j.1600-0463.2007.apm_630.x","volume":"115","author":"S Stepanovi\u0107","year":"2007","unstructured":"Stepanovi\u0107 S, Vukovi\u0107 D, Hola V, Bonaventura GD, Djuki\u0107 S, \u0106irkovi\u0107 I et al (2007) Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS 115:891\u2013899. https:\/\/doi.org\/10.1111\/j.1600-0463.2007.apm_630.x","journal-title":"APMIS"},{"key":"12092_CR15","doi-asserted-by":"publisher","first-page":"166731","DOI":"10.1016\/j.ijleo.2021.166731","volume":"237","author":"AJ Christy","year":"2021","unstructured":"Christy AJ, Suresh S, Nehru LC (2021) Enhanced antibacterial and photocatalytic activities of nickel oxide nanostructures. Optik 237:166731. https:\/\/doi.org\/10.1016\/j.ijleo.2021.166731","journal-title":"Optik"},{"key":"12092_CR16","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.3390\/microorganisms10071425","volume":"10","author":"C Zagaglia","year":"2022","unstructured":"Zagaglia C, Ammendolia MG, Maurizi L, Nicoletti M, Longhi C (2022) Urinary Tract infections caused by uropathogenic Escherichia coli strains-new strategies for an old pathogen. Microorganisms 10:1425. https:\/\/doi.org\/10.3390\/microorganisms10071425","journal-title":"Microorganisms"},{"key":"12092_CR17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s12879-025-10635-w","volume":"25","author":"P Mahshouri","year":"2025","unstructured":"Mahshouri P, Alikhani MY, Momtaz HE, Doosti-Irani A, Shokoohizadeh L (2025) Analysis of phylogroups, biofilm formation, virulence factors, antibiotic resistance and molecular typing of uropathogenic Escherichia coli strains isolated from patients with recurrent and non-recurrent urinary tract infections. BMC Infect Dis 25:267. https:\/\/doi.org\/10.1186\/s12879-025-10635-w","journal-title":"BMC Infect Dis"},{"key":"12092_CR18","doi-asserted-by":"publisher","first-page":"13492","DOI":"10.1021\/acsomega.3c00110","volume":"8","author":"A Karnwal","year":"2023","unstructured":"Karnwal A, Kumar G, Pant G, Hossain K, Ahmad A, Alshammari MB (2023) Perspectives on usage of functional nanomaterials in antimicrobial therapy for antibiotic-resistant bacterial infections. ACS Omega 8:13492\u201313508. https:\/\/doi.org\/10.1021\/acsomega.3c00110","journal-title":"ACS Omega"},{"key":"12092_CR19","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1186\/s13104-025-07318-9","volume":"18","author":"Y Malekzadegan","year":"2025","unstructured":"Malekzadegan Y, Abdi A, Khashei R (2025) Distribution of serogroup and pathogenicity Island markers of uropathogenic Escherichia coli from inpatients in a tertiary care hospital. BMC Res Notes 18:440. https:\/\/doi.org\/10.1186\/s13104-025-07318-9","journal-title":"BMC Res Notes"},{"key":"12092_CR20","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.jiac.2022.07.001","volume":"28","author":"T Matsumoto","year":"2022","unstructured":"Matsumoto T, Mikamo H, Ohge H, Yanagihara K, Weerdenburg E, Go O et al (2022) Distribution of extraintestinal pathogenic Escherichia coli O-serotypes and antibiotic resistance in blood isolates collected from patients in a surveillance study in Japan. J Infect Chemother 28:1445\u20131451. https:\/\/doi.org\/10.1016\/j.jiac.2022.07.001","journal-title":"J Infect Chemother"},{"key":"12092_CR21","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1089\/mdr.2018.0330","volume":"25","author":"A Noie Oskouie","year":"2019","unstructured":"Noie Oskouie A, Hasani A, Ahangarzadeh Rezaee M, Soroush Bar Haghi MH, Hasani A, Soltani E (2019) A relationship between O-serotype, antibiotic susceptibility and biofilm formation in uropathogenic Escherichia coli. Microb Drug Resist 25:951\u2013958. https:\/\/doi.org\/10.1089\/mdr.2018.0330","journal-title":"Microb Drug Resist"},{"key":"12092_CR22","doi-asserted-by":"publisher","first-page":"e118833","DOI":"10.5812\/jjm.118833","volume":"14","author":"EJ Mohammed","year":"2021","unstructured":"Mohammed EJ, Allami M, Sharifmoghadam MR, Bahreini M (2021) Relationship between antibiotic resistance patterns and O-serogroups in uropathogenic Escherichia coli strains isolated from Iraqi patients. Jundishapur J Microbiol 14:e118833. https:\/\/doi.org\/10.5812\/jjm.118833","journal-title":"Jundishapur J Microbiol"},{"key":"12092_CR23","first-page":"18","volume":"15","author":"N Tanko","year":"2021","unstructured":"Tanko N, Tolulope OA, Olajumoke BR, Ong EBB, Yahaya M, Olalekan OB (2021) Genetic relatedness in extended-spectrum beta-lactamase-producing Escherichia coli from clinical isolates using enterobacterial repetitive intergenic consensus polymerase chain reaction. Int J Health Sci (Qassim) 15:18\u201327","journal-title":"Int J Health Sci (Qassim)"},{"key":"12092_CR24","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.mgene.2018.06.001","volume":"17","author":"H Heidari","year":"2018","unstructured":"Heidari H, Halaji M, Taji A, Kazemian H, Abadi MSS, Sisakht MT et al (2018) Molecular analysis of drug-resistant Acinetobacter baumannii isolates by ERIC-PCR. Meta Gene 17:132\u2013135. https:\/\/doi.org\/10.1016\/j.mgene.2018.06.001","journal-title":"Meta Gene"},{"key":"12092_CR25","doi-asserted-by":"publisher","first-page":"252","DOI":"10.7416\/ai.2019.2288","volume":"31","author":"B Pourakbari","year":"2019","unstructured":"Pourakbari B, Mamishi S, Shokrollahi MR, Heydari H, Mahmoudi S, Banar M et al (2019) Molecular characteristics and antibiotic resistance profiles of Escherichia coli strains isolated from urinary tract infections in children admitted to children\u2019s referral hospital of Qom, Iran. Ann Ig 31:252\u2013262. https:\/\/doi.org\/10.7416\/ai.2019.2288","journal-title":"Ann Ig"},{"key":"12092_CR26","doi-asserted-by":"publisher","first-page":"100957","DOI":"10.1016\/j.genrep.2020.100957","volume":"21","author":"M Sadeghi","year":"2020","unstructured":"Sadeghi M, Sedigh Ebrahim-Saraie H, Mojtahedi A, Nikokar I, Atrkar Roushan Z (2020) Genetic diversity and prevalence of aminoglycoside modifying enzymes among Escherichia coli strains isolated from inpatients with urinary tract infections. Gene Rep 21:100957. https:\/\/doi.org\/10.1016\/j.genrep.2020.100957","journal-title":"Gene Rep"},{"key":"12092_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.22038\/NMJ.2018.05.004","volume":"5","author":"BK Hafshejani","year":"2018","unstructured":"Hafshejani BK, Mirhosseini M, Dashtestani F, Hakimian F, Haghirosadat BF (2018) Antibacterial activity of nickel and nickel hydroxide nanoparticles against multidrug resistance K. pneumonia and E. coli isolated urinary tract. Nanomed J 5:19\u201326. https:\/\/doi.org\/10.22038\/NMJ.2018.05.004","journal-title":"Nanomed J"},{"key":"12092_CR28","doi-asserted-by":"publisher","first-page":"104533","DOI":"10.1016\/j.jece.2020.104533","volume":"8","author":"M Maruthupandy","year":"2020","unstructured":"Maruthupandy M, Rajivgandhi GN, Quero F, Li WJ (2020) Anti-quorum sensing and anti-biofilm activity of nickel oxide nanoparticles against Pseudomonas aeruginosa. J Environ Chem Eng 8:104533. https:\/\/doi.org\/10.1016\/j.jece.2020.104533","journal-title":"J Environ Chem Eng"},{"key":"12092_CR29","doi-asserted-by":"publisher","first-page":"194","DOI":"10.37506\/ijfmt.v14i3.10352","volume":"14","author":"AJ Kzar","year":"2020","unstructured":"Kzar AJ (2020) Antimicrobial and biofilm inhibitory activity of nanoparticles against clinical isolates from urinary tract infection. Indian J Forensic Med Toxicol 14:194\u2013199. https:\/\/doi.org\/10.37506\/ijfmt.v14i3.10352","journal-title":"Indian J Forensic Med Toxicol"},{"key":"12092_CR30","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.3390\/nano15131023","volume":"15","author":"P Ebenezer","year":"2025","unstructured":"Ebenezer P, Kumara SB, Senevirathne SI, Bray LJ, Wangchuk P, Mathew A et al (2025) Advancements in antimicrobial surface coatings using metal\/metaloxide nanoparticles, antibiotics, and phytochemicals. Nanomaterials (Basel) 15:1023. https:\/\/doi.org\/10.3390\/nano15131023","journal-title":"Nanomaterials (Basel)"},{"key":"12092_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/microbiolspec.VMBF-0016-2015","volume":"4","author":"JM Munita","year":"2016","unstructured":"Munita JM, Arias CA (2016) Mechanisms of antibiotic resistance. Microbiol Spectr 4:1\u201337. https:\/\/doi.org\/10.1128\/microbiolspec.VMBF-0016-2015","journal-title":"Microbiol Spectr"},{"key":"12092_CR32","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1016\/j.bbamem.2015.02.017","volume":"1848","author":"S Maria-Neto","year":"2015","unstructured":"Maria-Neto S, de Almeida KC, Macedo MLR, Franco OL (2015) Understanding bacterial resistance to antimicrobial peptides: From the surface to deep inside. Biochim Biophys Acta 1848:3078\u20133088. https:\/\/doi.org\/10.1016\/j.bbamem.2015.02.017","journal-title":"Biochim Biophys Acta"},{"key":"12092_CR33","doi-asserted-by":"publisher","first-page":"e4327","DOI":"10.1002\/aoc.4327","volume":"32","author":"SM Hoseini-Alfatemi","year":"2018","unstructured":"Hoseini-Alfatemi SM, Karimi A, Armin S, Fakharzadeh S, Fallah F, Kalanaky S (2018) Antibacterial and antibiofilm activity of nanochelating based silver nanoparticles against several nosocomial pathogens. Appl Organometal Chem 32:e4327. https:\/\/doi.org\/10.1002\/aoc.4327","journal-title":"Appl Organometal Chem"},{"key":"12092_CR34","doi-asserted-by":"publisher","first-page":"1188743","DOI":"10.3389\/fmicb.2023.1188743","volume":"14","author":"MH Sarfraz","year":"2023","unstructured":"Sarfraz MH, Zubair M, Aslam B, Ashraf A, Siddique MH, Hayat S et al (2023) Comparative analysis of phyto-fabricated chitosan, copper oxide, and chitosan-based CuO nanoparticles: antibacterial potential against Acinetobacter baumannii isolates and anticancer activity against HepG2 cell lines. Front Microbiol 14:1188743. https:\/\/doi.org\/10.3389\/fmicb.2023.1188743","journal-title":"Front Microbiol"},{"key":"12092_CR35","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1186\/s12879-024-09471-1","volume":"24","author":"F Kakian","year":"2024","unstructured":"Kakian F, Arasteh N, Mirzaei E, Motamedifar M (2024) Study of MIC of silver and zinc oxide nanoparticles, strong and cost-effective antibacterial against biofilm-producing Acinetobacter baumannii in Shiraz, Southwest of Iran. BMC Infect Dis 24:593. https:\/\/doi.org\/10.1186\/s12879-024-09471-1","journal-title":"BMC Infect Dis"},{"key":"12092_CR36","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.2147\/IJN.S246310","volume":"15","author":"FY Ahmed","year":"2020","unstructured":"Ahmed FY, Farghaly Aly U, Abd El-Baky RM, Waly NG (2020) Comparative study of antibacterial effects of titanium dioxide nanoparticles alone and in combination with antibiotics on MDR Pseudomonas aeruginosa Strains. Int J Nanomed 15:3393\u20133404. https:\/\/doi.org\/10.2147\/IJN.S246310","journal-title":"Int J Nanomed"},{"key":"12092_CR37","doi-asserted-by":"publisher","unstructured":"Khashan KS, Sulaiman GM, Abdulameer FA (2016) Synthesis and antibacterial activity of CuO nanoparticles suspension induced by laser ablation in liquid. Arab J Sci Eng 41. https:\/\/doi.org\/10.1007\/s13369-015-1733-7. :301\u2009\u2013\u200910","DOI":"10.1007\/s13369-015-1733-7"},{"key":"12092_CR38","doi-asserted-by":"publisher","first-page":"e42899","DOI":"10.1016\/j.heliyon.2025.e42899","volume":"11","author":"F Aflakian","year":"2025","unstructured":"Aflakian F, Hashemitabar G (2025) Biosynthesized silver nanoparticles at subinhibitory concentrations as inhibitors of quorum sensing, pathogenicity, and biofilm formation in Pseudomonas aeruginosa PAO1. Heliyon 11:e42899. https:\/\/doi.org\/10.1016\/j.heliyon.2025.e42899","journal-title":"Heliyon"},{"key":"12092_CR39","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.2147\/IJN.S121956","volume":"12","author":"L Wang","year":"2017","unstructured":"Wang L, Hu C, Shao L (2017) The antimicrobial activity of nanoparticles: present situation and prospects for the future. Int J Nanomed 12:1227\u20131249. https:\/\/doi.org\/10.2147\/IJN.S121956","journal-title":"Int J Nanomed"},{"key":"12092_CR40","doi-asserted-by":"publisher","first-page":"e2305988","DOI":"10.1002\/smll.202305988","volume":"20","author":"X Wang","year":"2024","unstructured":"Wang X, Wang D, Lu H, Wang X, Wang X, Su J et al (2024) Strategies to promote the journey of nanoparticles against biofilm-associated infections. Small 20:e2305988. https:\/\/doi.org\/10.1002\/smll.202305988","journal-title":"Small"},{"key":"12092_CR41","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3390\/pharmaceutics14020247","volume":"14","author":"TI Ramos","year":"2022","unstructured":"Ramos TI, Villacis-Aguirre CA, L\u00f3pez-Aguilar KV, Santiago Padilla L, Altamirano C, Toledo JR et al (2022) The hitchhiker\u2019s guide to human therapeutic nanoparticle development. Pharmaceutics 14:247. https:\/\/doi.org\/10.3390\/pharmaceutics14020247","journal-title":"Pharmaceutics"},{"key":"12092_CR42","doi-asserted-by":"publisher","first-page":"113","DOI":"10.4103\/abr.abr_92_24","volume":"13","author":"H Salmani-Zarchi","year":"2024","unstructured":"Salmani-Zarchi H, Mousavi-Sagharchi SM, Sepahdoost N, Ranjbar-Jamalabadi M, Gross JD, Jooya H et al (2024) Antimicrobial feature of nanoparticles in the antibiotic resistance era: From mechanism to application. Adv Biomed Res 13:113. https:\/\/doi.org\/10.4103\/abr.abr_92_24","journal-title":"Adv Biomed Res"},{"key":"12092_CR43","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1476-0711-12-8","volume":"12","author":"H Momtaz","year":"2013","unstructured":"Momtaz H, Karimian A, Madani M, Safarpoor Dehkordi F, Ranjbar R, Sarshar M et al (2013) Uropathogenic Escherichia coli in Iran: serogroup distributions, virulence factors and antimicrobial resistance properties. Ann Clin Microbiol Antimicrob 12:8. https:\/\/doi.org\/10.1186\/1476-0711-12-8","journal-title":"Ann Clin Microbiol Antimicrob"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12092-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12092-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12092-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T12:38:04Z","timestamp":1781786284000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12092-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12092"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12092-3","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"7 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"None declared.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study has been approved by the Research Ethics Committee (No.IR.GUMS.REC.1401.426), the Vice Chancellor of Research and Technology, Guilan University of Medical Sciences, Rasht, Iran.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"951"}}